T Regulatory and Childhood Asthma
This is an epidemiologic study, examining environmental exposures and affect on immune development.
Description
This is an epidemiologic study, examining environmental exposures and affect on immune development. The study has completed enrollment
Status: Active, not recruiting (N/A). Started on October 1st, 2005.
Enrollment: 58 subjects
Study Type: Observational
Study Design:
- Observational Model: Case Control
- Time Perspective: Prospective
Conditions:
Interventions:
Eligibility
Inclusion Criteria:
- moderate to severe asthma
Exclusion Criteria:
-
- Gender
Both
- Mininum Age
6 Years
- Maximum Age
7 Years
- Healthy Volunteers
No
Resources
Source: University of Wisconsin, Madison
Authority: United States: Food and Drug Administration
Locations
-
University of Wisconsin
Madison
Wisconsin
53792
United States
Officials
James Gern, MD (Principal Investigator, University of Wisconsin, Madison)
Sponsors
University of Wisconsin, Madison (Lead Sponsor)
National Heart, Lung, and Blood Institute (NHLBI) (Collaborator)
References
None.
Links
- Date Verified
- September 1st, 2011
- First Received
- September 26th, 2011
- Last Changed
- September 26th, 2011
Information obtained from ClinicalTrials.gov on September 26, 2011. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.